Stay Updated with the Latest Invesco S&P 500 Momentum ETF SPMO News in Real Time
Find SPMO news now at Meyka AI. Stay informed with the latest Invesco S&P 500 Momentum ETF stocks updates, including price news, market analysis, and expert insights.
NEARUSD Rallies 9.2% to $5.34 as RSI Hits Extreme Overbought 85.9
NEARUSD jumped 9.2% to $5.34 on September 30, 2026, with RSI at 85.9 and volume 3.6x average, signaling an overheated rally.
Hyperliquid USD Climbs 3.7% to $89.22 as Bitcoin Drives Quarterly Close Rally
HYPEUSD surged 3.7% to $89.22 on September 30 as Bitcoin strength and $891.5M spot volume lift correlated assets into the quarterly close.
RBA Lifts Rates to 4.6%, Highest Since 2011, as Mortgage Pain Deepens
RBA lifts cash rate to 4.6%, highest since 2011, adding A$120 monthly to average mortgages. Fourth rate rise of 2026 as inflation stays above 3%.
Triple Lock Pension Scrapped From 2030: What Burnham’s Plan Means for Your Retirement
Andy Burnham scraps the triple lock pension from 2030, replacing it with inflation or 2.5% rises. The change will save £15bn yearly by 2040 but removes the earnings link that currently protects retirees.
Delta Rejects Starlink for Amazon Leo; Musk Warns of Customer Loss
Delta chooses Amazon Leo over Starlink for in-flight WiFi, prompting Elon Musk to warn of customer losses. United has 600+ Starlink-equipped planes; Delta’s rollout doesn’t start until 2028.
Quant USD Jumps 14.6% to $264.35 as RSI Hits Extreme Overbought 96
QNTUSD surged 14.6% in 24 hours to $264.35 with RSI at 96 and volume 21x average, signaling extreme overbought conditions.
Hedera USD Drops 15% to $0.1036 as RSI Cools From Overbought
HBARUSD fell 15% in 24 hours to $0.1036 on September 29, 2026, with RSI at 64.12 and volume 8.5x average.
Aave USD Surges 11.3% to $166.18 as RSI Hits Overbought 71.7
Aave USD jumped 11.3% to $166.18 in 24 hours with RSI at 71.7 and volume 3.2x average, signaling overbought conditions.
Swiss GDP Growth Forecast Jumps to 1.7% for 2026 on Pharma Surge
Switzerland raises 2026 GDP forecast to 1.7% from 0.9% after Q2 growth hits 1.5%, strongest since 2021. Pharma drives half the gains, but inflation expected to rise.